Update shared on 15 Dec 2025
Fair value Decreased 3.29%Narrative Update
Analysts have trimmed their price target on Raízen slightly, reducing fair value from approximately $1.98 to $1.92. They are factoring in a higher discount rate and more moderate revenue growth assumptions, partly offset by a marginally stronger profit margin outlook and a modestly lower future P/E multiple.
Valuation Changes
- Fair Value: Reduced slightly from R$1.98 to R$1.92, reflecting a modest downgrade in the intrinsic valuation.
- Discount Rate: Risen slightly from 21.96 percent to 22.25 percent, implying a marginally higher required return and risk premium.
- Revenue Growth: Fallen significantly from 108.54 percent to 70.04 percent, indicating a more conservative outlook on top line expansion.
- Net Profit Margin: Improved modestly from 5.58 percent to 5.69 percent, suggesting a slightly stronger long term profitability profile.
- Future P/E: Edged down from 2.71x to 2.62x, pointing to a marginally lower valuation multiple applied to future earnings.
Have other thoughts on Raízen?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
